Abstract
Purpose: The aim of this study was to assess the effects of topical application of a 10% (w/w) freeze-dried black raspberry (FBR) gel on oral intraepithelial neoplasia (IEN) variables that included histologic diagnoses and loss of heterozygosity (LOH) indices. Microsatellite instability and/or LOH at tumor suppressor gene - associated chromosomal loci have been associated with a higher risk for oral IEN progression to oral squamous cell carcinoma. Previously, our laboratories have shown that FBRs are well tolerated and possess potent antioxidant, apoptotic, and differentiation-inducing properties. Experimental Design: Each participant with IEN served as their own internal control. Before treatment, all lesions were photographed, and lesional tissue was hemisected to obtain a pretreatment diagnosis and baseline biochemical and molecular variables. Gel dosing (0.5 g applied four times daily for 6 weeks) was initiated 1 week after the initial biopsy. Genomic DNA was isolated from laser-captured basilar and suprabasilar surface epithelial cells followed by PCR amplification using primer sets that targeted known and presumed tumor suppressor gene loci associated with INK4a/ARF, p53, and FHIT. Allelic imbalance was determined by sequence analysis using normal participant tissues to establish microsatellite marker peak patterns and allele sizes. Results: Confirming earlier phase I data, none of the 27 participants developed FBR gel - associated toxicities. Furthermore, our results show histologic regression in a subset of patients as well as statistically significant reduction in LOH at tumor suppressor gene - associated loci. Conclusions: These preliminary data suggest that further evaluation of berry gels for oral IEN chemoprevention is warranted. © 2008 American Association for Cancer Research.
Cite
CITATION STYLE
Shumway, B. S., Kresty, L. A., Larsen, P. E., Zwick, J. C., Lu, B., Fields, H. W., … Mallery, S. R. (2008). Effects of a topically applied bioadhesive berry gel on loss of heterozygosity indices in premalignant oral lesions. Clinical Cancer Research, 14(8), 2421–2430. https://doi.org/10.1158/1078-0432.CCR-07-4096
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.